HAMEL ASSOCIATES, INC. NVS Holdings History
Number of Shares
41,060.00
Current Holdings Value*
$4.58 Mil
% of Portfolio
1.56%
Total Estimate Gain
$971,599.42
% of Total Estimate Gain
11.81%
HAMEL ASSOCIATES, INC.'s Novartis AG Holding Summary
As of 2025-03-31, HAMEL ASSOCIATES, INC. held 41,060.00 shares of Novartis AG(NVS), totaling $4.58 Mil. This investment constitutes 1.56% of their stock portfolio, and HAMEL ASSOCIATES, INC. now holds 0% of the outstanding Novartis AG(NVS) stock.
The initial trade took place in 2014Q1. And since then HAMEL ASSOCIATES, INC. has made 7 purchases of NVS, at an average price of $89.70, for a total of 91,741.00 shares. In addition, there have been 21 sales at an average price of $86.89 for 50,681.00 shares. Based on historical transaction data and NVS's current price of $116.83, HAMEL ASSOCIATES, INC.'s estimated gain on his NVS holdings is $971,599.42, reflecting a 11.81% gain to date.
HAMEL ASSOCIATES, INC. NVS ($116.83) Holding Chart
HAMEL ASSOCIATES, INC. NVS ($116.83) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1